Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Anavex Life Sciences Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.360 Good morning and welcome to the Annevex Life Sciences fiscal 2025 third quarter conference 00:00:05.360 -- 00:00:09.480 call. My name is Clint Tomlinson and I will be your host for today's call. 00:00:09.480 -- 00:00:13.320 At this time all participants are in listen only mode and later we will conduct a question 00:00:13.320 -- 00:00:17.420 and answer session before or during this session we would like to ask a question. 00:00:17.420 -- 00:00:19.880 Please use the Q&A box or raise your hand. 00:00:19.880 -- 00:00:23.360 Please note this conference is being recorded and the call will be available on Annevex's 00:00:23.360 -- 00:00:26.480 website at .annevex.com 00:00:26.480 -- 00:00:31.320 later today. With us today is Dr. Christopher Misling, President and Chief Executive 00:00:31.320 -- 00:00:35.540 Officer and Sondar Bohnush, Principal Financial Officer. 00:00:35.540 -- 00:00:40.980 Before we begin please note that this conference call the company will make some projections 00:00:40.980 -- 00:00:44.600 and forward looking statements. These statements are only predictions based on current 00:00:44.600 -- 00:00:50.540 information and expectations and involve a number of risks and uncertainties. 00:00:50.540 -- 00:00:55.160 We encourage you to review the company's filings with the SEC and this includes without 00:00:55.160 -- 00:01:00.280 limitation the company's forms 10K and 10Q which identify specific factors that 00:01:00.280 -- 00:01:05.080 may cause actual results or events to differ material from those described in these forward 00:01:05.080 -- 00:01:10.120 looking statements. These factors may include without limitation risks inherent in the 00:01:10.120 -- 00:01:14.420 development and or commercialization of potential prod...